secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silexion Therapeutics Corp (SLXN)
CIK:        0002022416
Form:       8-K
Filed at:   2025-01-17T23:59:59+00:00
Accession:  0001178913-25-000143
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silexion Therapeutics prices ~$5M public offering of shares and warrants at $1.35/unit
--------------------------------------------------------------------------------

- Gross proceeds expected ~$5M; net proceeds ~$4.26M after placement agent fees and expenses.
- Offering includes 3,703,703 ordinary shares (or pre-funded warrants) and identical number of warrants exercisable at $1.35 for 5 years.
- Closing expected January 17, 2025; placement agent H.C. Wainwright & Co. receives 7% cash fee plus 1% management fee.
- Proceeds to advance pre-clinical studies for KRAS-driven cancer RNAi therapies and for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325000143/0001178913-25-000143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2022416/000117891325000143/zk2532563.htm
  HTML page:      https://secwatch.observer/filing/0001178913-25-000143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer